Arcturus Therapeutics (ARCT) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.5
-1.09
-0.67
-0.26

Details

Expected EPS
-1.21611
Actual EPS
-0.26
Surprise EPS
0.96
Surprise Percent
+78.62%

Description

Arcturus Therapeutics (ARCT) has reported earnings of -0.26 per share for Q4 2024.

0 Comments

Share your thoughts